HIF inhibitors for ischemic retinopathies and cancers: options beyond anti-VEGF therapies S Subhani, DT Vavilala, M Mukherji Angiogenesis 19, 257-273, 2016 | 30 | 2016 |
Application of physiologically based absorption and pharmacokinetic modeling in the development process of oral modified release generic products S Subhani, C Kim, P Muniz, M Rodriguez, S van Os, E Suarez, ... European Journal of Pharmaceutics and Biopharmaceutics 176, 87-94, 2022 | 4 | 2022 |
Leveraging Physiologically Based Modelling to Provide Insights on the Absorption of Paliperidone Extended-Release Formulation under Fed and Fasting Conditions S Subhani, V Lukacova, C Kim, L Rodriguez-Vera, P Muniz, M Rodriguez, ... Pharmaceutics 15 (2), 629, 2023 | 1 | 2023 |
INVESTIGATION OF THE FOOD EFFECT ON THE IN VITRO-IN VIVO CORRELATION OF EXTENDED RELEASE FORMULATIONS: PALIPERIDONE CASE EXAMPLE. C Kim, P Muniz, M Rodriguez, R Cristofoletti, S van Os, S Subhani, ... CLINICAL PHARMACOLOGY & THERAPEUTICS 107, S72-S72, 2020 | | 2020 |